Literature DB >> 1764589

[Magnetic resonance tomography in patients with a heart valve prosthesis].

R Bachmann1, H J Deutsch, M Jüngehülsing, U Sechtem, H H Hilger, H Schicha.   

Abstract

Artificial valve prostheses are often regarded as a contraindication for magnetic resonance imaging (MRI), although preliminary in vitro studies suggested, that patients with these metallic implants might safely undergo MR examination. This study reports on the experience with a group of 89 patients with 100 heart valve prostheses who were examined by spin-echo MR and gradient-echo MR. MR examination was performed in all patients without complications. The spin-echo sequence showed advantages in the depiction of anatomical structures like paravalvular abscesses. Anatomical structures adjacent to the artificial valve were clearly visible and the metal components of the valves showed no or only small artifacts. Artifacts were accentuated when using gradient-echo sequences. Gradient-echo sequences provided valuable information regarding the presence of valvular insufficiency. Physiological valvular regurgitation was easy to differentiate from pathological paravalvular or transvalvular regurgitation. These results demonstrate that patients with artificial valve prostheses can be imaged by MR without risk and that prosthesis-induced artifacts do no interfere with image interpretation.

Entities:  

Mesh:

Year:  1991        PMID: 1764589     DOI: 10.1055/s-2008-1033306

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

Review 1.  Magnetic resonance imaging in valvular heart disease.

Authors:  M Schmidt; J Crnac; B Dederichs; P Theissen; H Schicha; U Sechtem
Journal:  Int J Card Imaging       Date:  1997-06

2.  Prevalence and Evolution of Susceptibility-Weighted Imaging Lesions in Patients With Artificial Heart Valves.

Authors:  Philipe S Breiding; Jana T Duerrenmatt; Felix G Meinel; Thierry Carrel; Florian Schönhoff; Felix Zibold; Johannes Kaesmacher; Jan Gralla; Thomas Pilgrim; Simon Jung; Urs Fischer; Marcel Arnold; Thomas R Meinel
Journal:  J Am Heart Assoc       Date:  2019-08-05       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.